Rest | Exercise at PASPmax | |||||
Normoxia | Hypoxia | p-value | Normoxia | Hypoxia | p-value | |
fC min−1 | ||||||
HAPE susceptible | 64±11 | 64±11 | 137±17 | 117±8 | <0.001 | |
Controls | 67±8 | 69±11 | 141±16 | 117±15 | <0.001 | |
p-value | 0.33 | 0.20 | 0.48 | 0.97 | ||
Sa,O2 % | ||||||
HAPE susceptible | 98±1 | 75±9 | <0.001 | 96±2 | 69±7 | <0.001 |
Controls | 98±1 | 78±8 | <0.001 | 97±2 | 72±5 | <0.001 |
p-value | 0.45 | 0.28 | 0.52 | 0.16 | ||
PASP mmHg | ||||||
HAPE susceptible | 25±5 | 48±10 | <0.001 | 57±14 | 69±13 | <0.001 |
Controls | 23±5 | 38±3 | <0.001 | 38±7 | 49±8 | <0.01 |
p-value | 0.42 | <0.001 | <0.001 | <0.001 | ||
W W·kg−1 | ||||||
HAPE susceptible | 2.4±0.5 | 1.2±0.3 | <0.001 | |||
Controls | 2.3±0.5 | 1.1±0.4 | <0.001 | |||
p-value | 0.56 | 0.33 |
Data are presented as mean±sd. PASPmax: maximum pulmonary artery systolic pressure; fC: cardiac frequency; HAPE: high-altitude pulmonary oedema; Sa,O2: arterial oxygen saturation; PASP: pulmonary artery systolic pressure; W: workload. Significances from normoxic to hypoxic condition and differences between subjects susceptible to HAPE and controls are indicated.